Organoid technology for tissue engineering

Tissue engineering has emerged as a promising avenue to address the limitations of organ development research models and donor shortages in transplantation. Dating back thousands of years, early attempts to replace lost teeth with bone-derived artificial ones foreshadowed the field's inception. Organoids, 3D biological structures mirroring in vivo organs, began with James G. Rheinwald and Howard Green's work in the 1970s.

Current organoid technologies focus on different embryonic layers:

• Ectoderm Organoids: Mimicking brain and skin tissues, ectoderm-derived organoids offer insights into neural development and diseases.
• Mesoderm Organoids: Successful replication of kidneys, originating from ureteric bud and intermediate mesoderm, showcases the potential of organoid technology, although further refinement is needed.
• Definitive Endoderm Organoids: Leveraging developmental similarities, these models enable the study of various endoderm organs.

Organoid applications span scientific inquiry and disease modeling, offering partial emulation of in vivo organs for studying development, diseases, cancers, and drug responses. Challenges remain, including organoid maturity, size suitability for transplantation, reproducibility, and the absence of vital in vivo tissue interactions components like vascular, nervous, and immune systems.